Results 1 to 10 of about 2,785 (177)

Ulipristal Acetate in Adenomyosis. [PDF]

open access: yesGynecol Minim Invasive Ther, 2022
Adenomyosis is defined as the invasion of the basal endometrium (stroma and glands) into the underlying myometrium. It may lead to abnormal uterine bleeding (AUB), pelvic pain, and infertility. The definitive treatment is hysterectomy. Some conservative measures have been used in patients willing to procreate.
Gonçalves-Henriques M   +6 more
europepmc   +3 more sources

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial. [PDF]

open access: yesEClinicalMedicine, 2023
BackgroundHeavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids.
Whitaker LHR   +20 more
europepmc   +7 more sources

Evaluation of marketing authorization and clinical implementation of ulipristal acetate for uterine fibroids. [PDF]

open access: yesHum Reprod, 2022
Peer reviewedPublisher ...
Middelkoop MA   +6 more
europepmc   +3 more sources

Ulipristal Acetate in Emergency Contraception [PDF]

open access: yesCollegium antropologicum, 2014
Despite the widespread availability of highly effective methods of contraception, unintended pregnancy is common. Unplanned pregnancies have been linked to a range of health, social and economic consequences.
Branko Radaković   +5 more
core   +6 more sources

Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids [PDF]

open access: yesNew England Journal of Medicine, 2012
The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear.In this double-blind noninferiority trial, we randomly assigned 307 patients with symptomatic fibroids and excessive uterine bleeding to receive 3 months of daily therapy ...
Donnez J1   +14 more
  +6 more sources

Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. [PDF]

open access: yesObstet Gynecol, 2018
Simon JA   +6 more
europepmc   +3 more sources

Rationale and design of ASTEROID 2, a randomized, placebo- and active comparator-controlled study to assess the efficacy and safety of vilaprisan in patients with uterine fibroids [PDF]

open access: yes, 2017
Background: Uterine fibroids (UFs) may be treated with progesterone receptor modulators (PRMs), which have been shown to reduce heavy menstrual bleeding and the size of UFs.
Bumbuliene, ana   +14 more
core   +1 more source

Mechanism of Action of Ulipristal Acetate for Emergency Contraception: A Systematic Review [PDF]

open access: yes, 2016
SUMMARYUlipristal acetate (UPA) is now recommended as first choice hormonal Emergency Contraception (EC), due to its higher efficacy and similar safety compared to Levonogestrel - EC.
Carlo Bastianelli   +2 more
core   +2 more sources

A myoma uteri diagnosztikája és kezelése [PDF]

open access: yes, 2016
Absztrakt A myoma a leggyakoribb nőgyógyászati jóindulatú daganat. Előfordulása rasszonként változó, általánosságban a reproduktív korú nők negyedét érinti.
Póka, Róbert, Török, Péter
core   +1 more source

Home - About - Disclaimer - Privacy